HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Vaccine | Image credit: weyo - stock.adobe.com
Cuts to HIV Vaccine Research Come Amid Challenges to Other Vaccines, Treatment

June 13th 2025

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving vaccine research and expertise behind.

Doctor communicating with patient | Image credit: bongkarn - stock.adobe.com
People Living With HIV Communicate Less With Health Care Providers

June 9th 2025

Machine learning | Image credit: putilov_denis - stock.adobe.com
Machine Learning Capable of Predicting Hyperlipidemia in People With HIV

May 28th 2025

Young adult HIV | Image credit: ViDi Studio - stock.adobe.com
Adolescents, Young Adults With HIV at Increased Risk of Mental Health Issues

May 20th 2025

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
Implementation of HIV Molecular Cluster Detection in US

May 15th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
June 14th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Medication Burden and Stigma Impacting Adherence Rates in Patients With MDR HIV
March 22nd 2023

Medication Burden and Stigma Impacting Adherence Rates in Patients With MDR HIV

Daniel Driffin, BS, MPH, provides insights regarding factors influencing patient adherence to multidrug-resistant HIV treatment.
Payers and Clinicians Impacted by CD4 Recovery
March 22nd 2023

Payers and Clinicians Impacted by CD4 Recovery

Dr Sension underlines the value of CD4 recovery from payer and clinician perspectives.
HIV image
March 18th 2023

Long-Acting ART Suppresses HIV in Individuals Without Virological Suppression

Ashley Gallagher
Study results indicates that the injectable antiretroviral therapy can benefit patients who are historically underserved and may face treatment barriers, including those with mental illness.
globe with red HIV ribbon on it
March 15th 2023

PEPFAR Helps More Than 20 Million People With HIV Access ART Worldwide

Hayden E. Klein
Since 2004, the number of individuals with HIV receiving antiretroviral therapy (ART) has increased 300-fold through the US President’s Emergency Plan for AIDS Relief (PEPFAR).
Considerations with Non-Adherence to Standard Background MDR HIV Therapy
March 15th 2023

Considerations with Non-Adherence to Standard Background MDR HIV Therapy

Key opinion leaders highlight barriers to MDR HIV treatment adherence.
Patient and Payer Considerations for Medication Regimen Adherence In MDR HIV Treatment Pathway
March 15th 2023

Patient and Payer Considerations for Medication Regimen Adherence In MDR HIV Treatment Pathway

The panel discusses considerations for payers as well as patient adherence to treatment in MDR HIV.
covid virus
March 10th 2023

COVID-19 Infection Linked to Higher Cytomegalovirus Response in People With HIV Receiving ART

Hayden E. Klein
Body mass index and nadir CD4 count were major factors in SARS-CoV-2 humoral immune repertoire among people with HIV.
doctor holding tablet, graphic of medical symbols
March 9th 2023

Study Finds Moderate to Good Performance in Externally Validated HIV Risk Models

Hayden E. Klein
Researchers found that only 8 of 18 HIV risk assessment models have been externally validated and show moderate-to-good discrimination ability for HIV infection prediction.
MDR HIV Treatment Approaches and Considerations for Therapeutic Adjustments
March 8th 2023

MDR HIV Treatment Approaches and Considerations for Therapeutic Adjustments

Therapy adjustments in MDR HIV are explored by Dr Sension.
Pharmacotherapeutic Treatment Options for Treating MDR HIV
March 8th 2023

Pharmacotherapeutic Treatment Options for Treating MDR HIV

Optimized background regimens are highlighted in the treatment approach for MDR HIV by Michael Sension, MD.
man holding pill bottle
March 4th 2023

High Resilience Linked to High PrEP Use Among Canadian MSM

Hayden E. Klein
The study also showed, despite an existing association between discrimination based on sexual orientation and HIV pre-exposure prophylaxis (PrEP) use, increased resilience reduced the effects of such discrimination on PrEP use.
pharmacy sign on building
March 2nd 2023

Walgreens, Doordash, Uber Partner to Improve HIV Medication Access

Hayden E. Klein
The 3 companies announced a partnership to provide free, same-day prescription delivery of HIV pre-exposure prophylaxis (PrEP) and antiretroviral medications.
Social Determinants of Health Impacting Patients Diagnosed with MDR HIV
March 2nd 2023

Social Determinants of Health Impacting Patients Diagnosed with MDR HIV

Dr Haumschild leads a discussion highlighting goals of therapy and social determinants of health affecting MDR HIV diagnosis and treatment.
Economic and Social Burdens Associated with MDR HIV
March 2nd 2023

Economic and Social Burdens Associated with MDR HIV

A panel of experts explore burdens impacting patients diagnosed with MDR HIV.
globe with red HIV ribbon on it
February 24th 2023

Global Case Series Characterizes Severe Form of Mpox in People With Advanced HIV

Hayden E. Klein
A global case series described a severe form of mpox linked to a 15% mortality rate among people living with HIV and low CD4 counts.
Resistance Mechanisms Leading to MDR HIV
February 23rd 2023

Resistance Mechanisms Leading to MDR HIV

Michael Sension, MD, provides insights on resistance mechanisms promoting MDR HIV.
Incidence and Prevalence of MDR HIV
February 23rd 2023

Incidence and Prevalence of MDR HIV

Ryan Haumschild, PharmD, MS, MBA, opens a panel discussion surrounding the incidence and prevalence of multidrug-resistant (MDR) HIV.
coffee and newspaper
February 21st 2023

What We’re Reading: Fifth Person Cured of HIV; New Possible Future Stroke Treatment; Pushback on Proposed FDA Healthy Food Guidelines

AJMC Staff
A fifth person has been cured of HIV following a stem cell transplant for cancer; a new study examining a treatment of spinal cord stimulation after stroke had favorable results; some food companies enraged by proposed FDA healthy food guidelines.
globe with red HIV ribbon on it
February 17th 2023

HIV Screening, PrEP Program in Zambia May Serve as Model for Prisons Worldwide

Hayden E. Klein
An HIV prevention and treatment program implemented in Zambian criminal justice facilities demonstrated high levels of pre-exposure prophylaxis (PrEP) uptake among at-risk individuals.
HIV test
February 10th 2023

CDC Report Highlights 2021 Trends in HIV Testing, Treatment, Risk Behaviors Among MSM

Hayden E. Klein
Interviews with 2241 men who have sex with men (MSM) without HIV showed high levels of HIV testing, but lower levels of preventative treatment in 2021.
coffee and newspaper
February 8th 2023

What We’re Reading: Biden’s SOTU Underscores Health Progress, Plans; DC Sees Rising HIV Diagnoses; The Pill Club to Pay $18.3M in Medicaid Fraud

AJMC Staff
Biden’s State of the Union (SOTU) address emphasized drug access for those on Medicare, the Cancer Moonshot, and more; HIV diagnoses are increasing in Washington, DC, from missed wellness visits and preventive visits upended during the start of COVID-19; California online women’s pharmacy The Pill Club will pay $18.3 million in Medicaid fraud settlement with California.
What We’re Reading: J&J Ends HIV Vaccine Trial; Deaths After Abortion Bans; Sanofi Looks to Hemophilia A Drug
January 19th 2023

What We’re Reading: J&J Ends HIV Vaccine Trial; Deaths After Abortion Bans; Sanofi Looks to Hemophilia A Drug

AJMC Staff
Johnson & Johnson (J&J) ends late-stage HIV vaccine trial; mothers in states with abortion bans are almost 3 times more likely to die before, during, and after birth; Sanofi hopes to release a drug for hemophilia A in 2023.
metal spoon holding vitamin D pills
January 4th 2023

Women With HIV More Likely to Get Vitamin D From Supplements, Not Diet

Hayden E. Klein
A study showed that Canadian women living with HIV were less likely to get vitamin D through dairy consumption, but more likely to take vitamin D supplements, compared with women without HIV.
the top 5 HIV content of 2022
December 28th 2022

Top 5 Most-Viewed HIV Content of 2022

Justina Petrullo
This year’s most-viewed HIV content focused on disparities in HIV care, an emerging nonepidemic Kaposi sarcoma subtype, and the need for more research on hepatitis B endurance.
New York City skyline panorama at sunrise
December 22nd 2022

HIV Self-testing Relatively Uncommon Among MSM in Urban Areas

Hayden E. Klein
Of 6563 men who have sex with men (MSM) living in urban areas in 2017, only 7.7% reported HIV self-testing in the past year.
HIV PrEP pill in hand
December 17th 2022

USPSTF Recommends HIV PrEP

Hayden E. Klein
The US Preventive Services Task Force (USPSTF) announced its recommendation for HIV pre-exposure prophylaxis (PrEP).
doctor talking to patient with clipboard on desk
December 15th 2022

Conversations Around HIV PrEP With Adolescents Vary Between Urban, Rural Family Physicians

Hayden E. Klein
This new study shows that family medicine physicians in rural areas tend to be less comfortable in HIV pre-exposure prophylaxis (PrEP)-related clinical activities and conversations with adolescents than those in urban areas.
hundred dollar bills covered by pills
December 7th 2022

ICYMI: Top Highlights From AMCP Nexus 2022

AJMC Staff
Perry N. Halkitis, PhD, MS, MPH
December 1st 2022

Contributor: On World AIDS Day—Lessons Drawn From HIV, Monkeypox, and COVID-19

Perry N. Halkitis, PhD, MS, MPH
Dr Halkitis is currently working on his new book "People, Politics, & Public Health: How the American People Created the HIV, COVID-19, and Other Modern-Day Pandemics," to be published by Johns Hopkins University Press.
HIV Care Should Be Comprehensive, Says Dr Jana Dickter
November 29th 2022

HIV Care Should Be Comprehensive, Says Dr Jana Dickter

Hayden E. Klein Skylar Jeremias
Jana K. Dickter, MD, associate clinical professor, Division of Infectious Diseases, City of Hope, addresses what health systems need to do to improve HIV therapy accessibility and affordability.
<1
...
456789101112
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo